Microbot Medical Inc.

NasdaqCM MBOT

Microbot Medical Inc. Price to Sales Ratio (P/S) on February 06, 2025

Microbot Medical Inc. Price to Sales Ratio (P/S) is NA on February 06, 2025, a NA change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Microbot Medical Inc. 52-week high Price to Sales Ratio (P/S) is 484.84 on January 06, 2025, which is NA below the current Price to Sales Ratio (P/S).
Microbot Medical Inc. 52-week low Price to Sales Ratio (P/S) is 132.83 on April 25, 2024, which is NA below the current Price to Sales Ratio (P/S).
Microbot Medical Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 174.39.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NasdaqCM: MBOT

Microbot Medical Inc.

CEO	Mr. Harel Gadot
IPO Date	March 25, 1992
Location	United States
Headquarters	25 Recreation Park Drive
Employees	21
Sector	Technology
Industries Robotics 3D Printing Medical Instruments

Description

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Key trends

Past 5 years